Loading…

Thermo Fisher Scientific has built a new $40 million, 120,000-square-foot manufacturing facility in Lenexa, Kansas, dedicated to producing viral transport media for COVID-19 testing. The plant was completed in six weeks and adds over 300 jobs, with production capacity of 8 million units per week.
“We have a proven blueprint for high-quality VTM production in Lenexa and look forward to bringing significant new capacity on line as quickly as possible to continue the necessary testing ramp-up in the U.S.”fiercebiotech.com
Summarized from public sources; check the original articles before acting on it.